Literature DB >> 19185848

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.

Tracy-Ann Read1, Marie P Fogarty, Shirley L Markant, Roger E McLendon, Zhengzheng Wei, David W Ellison, Phillip G Febbo, Robert J Wechsler-Reya.   

Abstract

The growth of many cancers depends on self-renewing cells called cancer stem cells or tumor-propagating cells (TPCs). In human brain tumors, cells expressing the stem cell marker CD133 have been implicated as TPCs. Here we show that tumors from a model of medulloblastoma, the Patched mutant mouse, are propagated not by CD133(+) cells but by cells expressing the progenitor markers Math1 and CD15/SSEA-1. These cells have a distinct expression profile that suggests increased proliferative capacity and decreased tendency to undergo apoptosis and differentiation. CD15 is also found in a subset of human medulloblastomas, and tumors expressing genes similar to those found in murine CD15(+) cells have a poorer prognosis. Thus, CD15 may represent an important marker for TPCs in medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185848      PMCID: PMC2664097          DOI: 10.1016/j.ccr.2008.12.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  54 in total

1.  Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.

Authors:  Jennifer Pogoriler; Kathleen Millen; Manuel Utset; Wei Du
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

Review 2.  The neurobiology of neurooncology.

Authors:  Tracy-Ann Read; Balazs Hegedus; Robert Wechsler-Reya; David H Gutmann
Journal:  Ann Neurol       Date:  2006-07       Impact factor: 10.422

Review 3.  In search of the medulloblast: neural stem cells and embryonal brain tumors.

Authors:  Charles G Eberhart
Journal:  Neurosurg Clin N Am       Date:  2007-01       Impact factor: 2.509

4.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

5.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

6.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

7.  Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma.

Authors:  Craig D Peacock; Qiuju Wang; Gregory S Gesell; Ian M Corcoran-Schwartz; Evan Jones; Jynho Kim; Wendy L Devereux; Jonathan T Rhodes; Carol A Huff; Philip A Beachy; D Neil Watkins; William Matsui
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

8.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

9.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.

Authors:  Gentao Liu; Xiangpeng Yuan; Zhaohui Zeng; Patrizia Tunici; Hiushan Ng; Iman R Abdulkadir; Lizhi Lu; Dwain Irvin; Keith L Black; John S Yu
Journal:  Mol Cancer       Date:  2006-12-02       Impact factor: 27.401

10.  Patching the gaps in Hedgehog signalling.

Authors:  Rajat Rohatgi; Matthew P Scott
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

View more
  158 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 3.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

Review 4.  Stem cell glycolipids.

Authors:  Makoto Yanagisawa
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

5.  Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

Authors:  J Rodriguez-Blanco; L Pednekar; C Penas; B Li; V Martin; J Long; E Lee; W A Weiss; C Rodriguez; N Mehrdad; D M Nguyen; N G Ayad; P Rai; A J Capobianco; D J Robbins
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

6.  A safer stem cell: on guard against cancer.

Authors:  Rahul Jandial; Evan Y Snyder
Journal:  Nat Med       Date:  2009-09       Impact factor: 53.440

7.  Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15.

Authors:  Xing-Gang Mao; Xiang Zhang; Xiao-Yan Xue; Geng Guo; Peng Wang; Wei Zhang; Zhou Fei; Hai-Ning Zhen; Si-Wei You; Hao Yang
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.

Authors:  Africa Fernandez-L; Paul A Northcott; James Dalton; Charles Fraga; David Ellison; Stephane Angers; Michael D Taylor; Anna Marie Kenney
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

9.  RalA is overactivated in medulloblastoma.

Authors:  Kevin F Ginn; Ben Fangman; Kaoru Terai; Amanda Wise; Daniel Ziazadeh; Kushal Shah; Robyn Gartrell; Brandon Ricke; Kyle Kimura; Sharad Mathur; Emma Borrego-Diaz; Faris Farassati
Journal:  J Neurooncol       Date:  2016-08-26       Impact factor: 4.130

10.  Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.

Authors:  Holly Lindsay; Yulun Huang; Yuchen Du; Frank K Braun; Wan Yee Teo; Mari Kogiso; Lin Qi; Huiyuan Zhang; Sibo Zhao; Hua Mao; Frank Lin; Patricia Baxter; Jack M Su; Keita Terashima; Laszlo Perlaky; Murali Chintagumpala; Adekunle Adesina; Ching C Lau; D Williams Parsons; Xiao-Nan Li
Journal:  J Neurooncol       Date:  2016-03-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.